retatrutide trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a retatrutide phase 2 trial results

The Dual-Hormone Approach of Mounjaro Mounjaro is a unique medication that targets not one, but two key hormones responsible for regulating appetite and metabolism: GLP-1 and GIP

Advancements in GLP-1 RA formulations, including once-a-week injectables and oral options, have enhanced patient convenience and adherence

Romantic attachment is a much more complex neurobiological process than a single reward pathway. She added: We are seeing a range of experiences in clinical practice

If you are considering stopping the medication, say so

Some people turn to microdosing in hopes of easing side effects or maintaining weight loss

Hannah S Lyons, University of Birmingham, Institute of Metabolism and Systems Research, Birmingham, B15 2TT, UK